Sign in
Taking people in United StatesNo phase

Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches

Key facts

Who runs it
Northwell Health
Where
Manhasset, United StatesSee the site
Trial code
Status
Recruiting
People taking part
25 people, planned
Started
1 Apr 2021
Expected to end
1 Dec 2027
Type of study
Observational
Treatments tested
  • Methylprednisolone
Record updated
26 August 2026

Who can take part

Age
18 years and older
Sex
Women and men

The registry criteria, word for word

Show all 24 criteriaShow less

Who can take part

  • Provision of signed and dated informed consent form (in person or via telehealth)
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, aged >18 years old
  • Ability to take oral medication and be willing to adhere to the study regimen as described in this protocol
  • Patients presenting with all types of post-concussive headache with >5/10 in severity on the numerical analog scale
  • Headache that occurs for > 4 hours per day
  • Headache that occurs every day
  • Headache that began after concussion, patient was diagnosed at an outpatient clinic or was hospitalized
  • Headache developed within 7 days post-injury and patient presenting within 30 days from initial trauma
  • A diagnosis of concussion
  • If a patient is taking another pain medication, this still be included in the stud

Who cannot take part

  • Any contraindication to corticosteroids
  • Currently on corticosteroids for another reason
  • Any evidence of known intracranial hemorrhage on neuroimaging
  • Allergy or sensitivity to corticosteroids
  • Active Tuberculosis
  • Participants with fungal infection
  • Age < or = 18
  • Headache developing after 7 days post injury and patient presenting after 30 days from initial trauma
  • Headache occurs < 4 hours per day
  • Headache does not occur daily
  • Headache is < 5 in severity on numerical analog scale
  • Presence of increase in intracranial pressure or papilledema
  • Active pregnancy

This trial is currently available in United States.

  • Northwell Health North Shore University HospitalManhasset, United StatesContact: Jamie Ullman, MDTaking people

About the trial

What the trial wants to find out

This novel pilot project will assess the effectiveness of corticosteroids in treatment of acute post-concussion headache. The investigators hypothesize that the use of corticosteroids will cause significant headache reduction in frequency and/or intensity than individuals who undergo the current standard of care. Additionally, the investigators hypothesize that corticosteroid use will lead to a reduction in other somatic symptoms including vestibular symptoms, leading to quicker return to school, work, and/or ability to play sports.

Treatments tested

  • Methylprednisolone

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Assessment of the Efficacy of Medrol Dose Pack for Post-Concussive Headaches
Record updated
26 August 2026